Resident & Fellow Research

Residents and Fellows in the Department of Obstetrics, Gynecology & Women's Health are encouraged to develop and pursue research areas of interest and relevance with a faculty research mentor. The Fellowship programs both have dedicated blocks of protected research time for further exploration of projects and research interests.


In compliance with the ACGME, all residents must complete at least one research project during their time in the program. The ultimate goal of this research is to publish or present at a national meeting by the resident's fourth year. Residents are encouraged to speak with their research mentors to begin development of project ideas during their first year in residency. More information on the timeline for research projects can be found in the Residency Research Handbook, or by contacting Trisha Pederson, Residency Coordinator, at


When funds are available, each fellow will be awarded $7,500 towards research activities and travel for the three-year term they are with the Fellowship Program. More information can be found in the Fellowship Program Manuals, or in the Fellow Research Handbook or by contacting Deborah Egger-Smith at

Resident and Fellow Research Day

Research Day 2021

Resident + Fellow Research Day - 2021

Will be on Monday, May 24, from 7:00 - 3:00 pm, Virtual Presentations via Zoom

This day-long conference was established by the Department of Obstetrics, Gynecology, and Women's Health as an opportunity for 4th-year residents, and the fellows in the Gynecologic Oncology and Maternal-Fetal Medicine Fellowships, to present the results of a research project to the faculty and guests.

We are pleased to announce the 2019 Awards for Best Resident Research Presentations:

  • Annelise Wilhite, MD, PGY3, "Provider Adherence to Surgical Guidelines for Risk Reducing Salpingo-oophorectomy," Research mentor: Britt Erickson, MD
  • Malinda Schaefer, MD, PGY3, "Assessment of pregnant women's knowledge and attitudes towards prevention of cytomegalovirus infection in the Minneapolis metropolitan area," Research mentor: Jessica Nyholm, MD
RESEARCH DAY PROGRAM 2020 (2021 Coming Soon!)

Highlighted Resident Studies

Anderson Pic


Dr. Leah Anderson, PGY4

Study: "Perceptions of Long-Acting Reversible Contraceptives (LARCs) and Barriers to Obtaining LARCs Among Low Income Women"

Research Mentor: Dr. Christy Boraas

In a cross-sectional survey, more barriers exist for low-income women desiring long-acting reversible contraception.


Sabrina Bedell

Dr. Sabrina Bedell, PGY4

Study: "Whether additional treatment in stage I vulvar cancer patients with close or positive surgical margins improved health outcomes for women."

Research Mentor: Dr. Britt Erickson

Under the guidance of my mentor, Dr. Erickson, we performed a retrospective analysis of patient data. We found that vulvar cancer patients who receive re-excision or adjuvant vulvar radiation do not have a greater chance of recurrence-free survival or overall survival. It is essential that patients receive the appropriate treatment for their circumstances, and as the Hippocratic Oath states, "first, do no harm." The manuscript for my study was recently recognized in ASC/Medpage press in an article about the surgical margins for vulvar cancer. Other research projects of interest to me have been on environmental exposures (specifically phthalates) and hypertension in pregnancy, molecular markers in endometrial cancer, and quality improvement. As I am currently applying for Gynecologic Oncology Fellowship, I am interested in applying my experience with the environmental exposures research to a gynecologic oncology patient population, as well as continuing to build on prior research in vulvar and endometrial cancer.

Congrats to Dr. Bedell for her research being cited in an article that made the ASC/MedPage press! Click HERE to read.


Study: "First trimester phthalates in the development of hypertensive diseases of pregnancy"

Research Mentor: Dr. Britt Erickson

This single site, retrospective cohort study of patients with stage IA or IB vulvar squamous cell carcinoma demonstrated no improvement in recurrence-free survival or overall survival with any additional treatment following primary surgical resection. Larger studies are warranted.